Mary Ann Liebert, Inc. Submission Benefits Package
Your submission to The Journal of Alternative and Complementary Medicine: Research on Paradigm, Practice, and Policy provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:
- Complimentary 12-month AuthorCite® membership
Exclusively licensed by Mary Ann Liebert, Inc., AuthorCite® delivers a 360-degree view of your article from submission to publication to market impact. With an AuthorCite® membership, you’ll receive end-to-end manuscript submission tracking, a custom online microsite to promote you and your research, a professional suite of metrics and analytics to measure the impact of your article, 30-day OpenLink™ article sharing, and much more.
- Rapid, rigorous peer-review and editorial attention
- Immediate deposit to PubMed and other indexing services upon online publication
- Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
- Fast Track online-ahead-of-print publication
- Global availability in over 170 countries
- Open Access publication options
Submitting Your Manuscript
Submitting your manuscript to The Journal of Alternative and Complementary Medicine delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. This includes a one-year membership to AuthorCite™, a robust author services platform for increasing the visibility of your research, and includes the ability to freely share your article for 30 days. The Journal of Alternative and Complementary Medicine carries a manuscript processing charge* of $49.00 USD upon submission of each new manuscript.
Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system. Please note: Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.
Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.
Click here to submit your paper via our fast and user-friendly electronic submission system.
Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/jaltcompmed and click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.
Please be sure to follow the Instructions for Authors below on Manuscript Preparation. Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge.
*The manuscript processing charge is independent of editorial decision and is non-refundable.
Instructions for Authors
The Journal of Alternative and Complementary Medicine: Research on Paradigm, Practice, and Policy is a peer-reviewed journal. It includes observational and analytical reports, ideas, commentary, and opinions on therapies currently thought to be outside the realm of conventional Western biomedicine that are gaining interest and warranting research to assess therapeutic value. The Journal includes current concepts in clinical care, including case reports, which will be valuable for physicians and other health care professionals who are seeking to evaluate and integrate these therapies into patient care protocols.
A primary goal of this international peer-reviewed journal is the establishment of rigorous and appropriate research methodologies; the Journal will develop and encourage publication standards to foster effective and reliable measurement, data collection, analysis, and interpretation. The Journal does not publish papers that have been submitted elsewhere.
Case Reports may be submitted, but it is important to note that JACM will consider only truly extraordinary cases with contain exceptional findings that will contribute significantly to the field.
JACM does NOT publish studies containing animal models, lab-based cellular work, en/ex-vivo or en/ex-vitro studies, nor does it accept opinion and/or perception pieces.
Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.
Upon acceptance of any manuscript, all authors will receive a follow-up email with instructions on how to complete our online Copyright Agreement form. It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications.
FAILURE BY ALL AUTHORS TO SUBMIT THIS FORM WILL RESULT IN A DELAY OF PUBLICATION.
The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.
INSTRUCTIONS FOR AUTHORS
Please read all the instructions to authors before submitting.
Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded onto Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
Please suggest of up to five potential reviewers familiar with the field. Anyone whom you do not want to be considered should also be named. However, final reviewer selection is at the discretion of the Editor and the Editorial Office.
All material published in the Journal will be copyrighted by Mary Ann Liebert, Inc., and may not be republished without written permission.
Authorship. All authors, including co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a paper assumes responsibility and accountability for the results.
Changes in authorship are not permitted after a paper is accepted for publication.
Preparation of Manuscript. Manuscripts should be submitted double spaced in Microsoft Word format. Leave ample margins on both sides, top, and bottom.
For controlled trials of acupuncture, use our preferred reporting criteria based on the STRICTA Guidelines, which are at: www.stricta.info/ or in: MacPherson et al. Standards for reporting interventions in controlled trials of acupuncture: The STRICTA recommendations. J Altern Complement Med 2010;16(10):ST1–ST 14.
For randomized controlled trials of homeopathy, use our preferred reporting criteria based on the supplement to the CONSORT Guidelines in: Dean et al. Reporting data on homeopathic treatments (Red Hot): A supplement to CONSORT. J Altern Complement Med 2007;13(1):19–23.
Guidelines on Length. Original Research articles should be 3,000 words or less, with abstracts limited to 300 words. Review articles should be 4,500 words or less, with abstracts limited to 400 words. Case Studies should be less than 2000 words; and Short Reports should be less than 1500 words with no more than two tables and one illustration, and up to ten references. Articles that are longer than these guidelines require permission from the Editor-in-Chief prior to submission. We may accept unsolicited editorials of up to 1000 words, which will be externally peer reviewed. Letters to the Editor should ordinarily be no longer than 500 words with no more than ten references, except in exceptional circumstances and, in which case, the argument for this should be laid out in an accompanying letter. One table or illustration may accompany a letter. Personal view articles; Paradigm articles; drug/therapy/intervention reports; critical reviews; debates; and reports drawing attention to clinical controversies, problems, and solutions will be welcomed. Abstracts, references, acknowledgment, disclosures, or figure legends are excluded from the word limit.
Title Page. Include a title page as part of the main text file. The title page should include the contributors’ names with highest academic degrees, affiliations, and a running head of no more than 45 characters.
Abstract. Provide a structured abstract as part of the main text file, double spaced, of no more than 300 words with the following headings when applicable: Objectives, Design, Settings/Location, Subjects, Interventions, Outcome Measures, Results, and Conclusions. Do not place references in the abstract.
Text. Organize the text as follows: Introduction, Materials and Methods, Results, Discussion, Conclusions, Acknowledgments, and References. Use only standard abbreviations from the AMA’s Manual for Authors & Editors or the Council of Biology Editors Style Manual. At the first usage, spell out each term and give the abbreviation in parentheses. Thereafter, use only the abbreviation. It is not necessary to spell each standards of measure, even at first usage. For botanical names, use the Linn. classification in its first appearance in the text; thereafter, use either the common or Latin name. Use generic names for drugs if possible. If you use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, city, and state in parentheses. Spell out all characters not on your keyboard. Our typesetter will convert the text to symbols (e.g., Greek alpha would become a).
Acknowledgments. Acknowledge only those people and institutions that have made significant contributions to the study. Details of sources of funding must be given.
Disclosure Statement. Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state: “No competing financial interests exist.”
References. Cite references within the text by a superscripted Arabic number as in the following example:
[ . . . as described previously.1,4]. List references by number (1,2, etc.) in the order in which they appear. Use journal abbreviations as provided by the MEDLINE,® National Library of Medicine. List all authors up to four authors. If there are more than four authors, list three and then et al. Do not put personal communications or unpublished data (e.g., theses, dissertations, and submitted articles) in the list of references. They should be referred to in the text in parentheses or as footnotes in the text. Include, among the references, articles accepted but not yet published; designate the journal, as “in press.” Please send a copy of related articles listed as “in press,” particularly if they include methods published elsewhere. If it is necessary to cite an abstract, this should be so designated. Authors are responsible for the accuracy of the references, and are reminded that inaccurate references are highly frustrating to the reader, the cited author, and indexing services. Please follow the samples below. Translate titles of papers into English and place the original language in square brackets.
Sample References: Journal article: Jobst KA. Acupuncture in asthma and pulmonary disease: An analysis of efficacy and safety. J Altern Complement Med 1996;2:179–206.
Book: Ersser SJ. Nursing as a Therapeutic Activity: An Ethnography. Avebury, UK: Aldershot, 1997:371.
Edited book: Fulford KWM, Ersser SJ, Hope T, eds. Essential Practice in Patient-Centered Care. Oxford: Blackwell Science, 1996.
Chapter in a book: Van Wijk R, Wiegant FA. Physiological effects of homeopathic medicines in closed phials: A critical evaluation. In: Endler PC, Schulte J, eds. Ultra High Dilution Physiology and Physics. Boston: Kluwer Academic Publishers, 1994:81–98.
Website: List up to four authors or three authors and et al. and initials, title of article, name of site, and URL, starting with www. Include month, date, and year accessed.
Corresponding Address. Following the references, provide the name, complete postal address, and e-mail address of the person to whom correspondence should be sent.
Legends. Double space legends for art in a separate file. Provide explanations for any abbreviations, arrows, etc., on the artwork. If the art is taken from a copyrighted publication, credit must be given in the legend.
Tables. NOTE: Tables should NOT be included in your main text file. Tables should be submitted in a separate file that contains only tables and their corresponding table titles (and, if applicable, table footnotes). Double space each table in a separate file (labeled like this example: Jones.Table 1), and provide a short title for each table. Cite tables in sequence in the text. Explain abbreviations used in the table in footnotes. If the table is taken from a copyrighted publication, give credit in a footnote.
NOTE: Figures or illustrations should NOT be included in your main text file. Each figure should be submitted as an individual file. All illustrations should be numbered and labeled. The top of the illustration should be indicated. A legend should be supplied for each illustration and all legends should be numbered consecutively and provided (double spaced). Figures should be numbered in the order cited in the text. Images should not show the name of the manufacturer. Figures will be reduced, so please do not submit large figures/graphs that contain small type because the text within the figure will not be readable after reduction.
Please follow these guidelines for submitting figures:
- Do NOT embed art files into a Word or PDF document.
- Line illustrations should be submitted at 900 dpi.
- Halftones and color should be a minimum of 300 dpi.
- Save as either .tiff or .eps files.
- Color art must be saved as CYMK—not RGB.
- Submit black and white art as grayscale—not RGB.
- Do NOT submit PowerPoint, .pdf, Bitmap, or Excel files.
Please name your figure and table files with the first author’s name (i.e., SmithFig1.tif SmithTable2.doc). Label figures and tables inside the files in addition to naming the file with the figure or table number.
Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the Journal for reproduction. Obtain and submit written permission from authors to cite unpublished data or papers still in press.
Adherence to these submission requirements is essential. Manuscripts submitted without these elements in place may be returned without being peer reviewed, and the submission fee will not be refunded.
Once a paper is accepted, changes in authorship in page proofs are NOT permitted under any circumstance.
It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper. This designation should be determined at the time of submission. Additions to corresponding authors are not permitted after acceptance or in page proofs.
Page proofs will be sent to the (one) corresponding author as designated when the manuscript was uploaded to Manuscript Central. It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof. The Publisher will not accept corrections from multiple authors.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801. Telephone: 914-740-2100; Fax: 914-740-2108; E-mail: firstname.lastname@example.org; Website: www.liebertpub.com
The views, opinions, findings, conclusions and recommendations set forth in any
Journal article are solely those of the authors of those articles and do not necessarily
reflect the views, policy or position of the Journal, its Publisher, its editorial
staff or any affiliated Societies and should not be attributed to any of them.